Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $749.8M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Almirall EUR 2.29B 527.4M Jun/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amarin USD 341M 4M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Astellas Pharma JPY 4.02T 1.46T Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Charles River Laboratories USD 7.31B 57M Sep/2025
Exact Sciences USD 10.36B 334M Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
MacroGenics USD 114M 8M Feb/2026
Moderna USD 10.09B 581M Sep/2025
Myriad Genetics USD 494M 316M Jun/2025
Pacira USD 1.16B 51M Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Takeda JPY 7.64T 774.9B Dec/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025